Oxidative stress in the renal medulla

肾髓质的氧化应激

基本信息

  • 批准号:
    6656539
  • 负责人:
  • 金额:
    $ 33.6万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2002
  • 资助国家:
    美国
  • 起止时间:
    2002-09-01 至 2003-08-31
  • 项目状态:
    已结题

项目摘要

In addition to their role in countercurrent exchange, descending vasa recta (DVR) are resistance vessels through which blood flow to the renal medulla is supplied. The general hypothesis of this program project grant is that a fundamental mechanism that leads to hypertension is enhanced production of reactive oxygen species (ROS). The general hypothesis to be tested in this subproject is that, during hypertension, increased ROS production in the medulla leads to reduction of nitric oxide (NO) bioavailability and enhanced vasomotor tone of DVR. Preliminary data shows that angiotensin II (AngII) enhances ROS formation in DVR and nephrons and that blockade of ROS formation increase DVR NO formation and blunts vasoconstriction. We will explore our central hypothesis our central hypothesis with the following specific aims. In aim 1 we will test the hypothesis that ROS formation modulates NO generation in outer medullary DVR (OMDVR) isolated from the vascular bundles and outer medullary nephrons isolated from the interbundle region. As an index of NO bioavailability, we will test the effect of AngII induced hypertension on OMDVR vasodilation by acetylcholine. We will also directly measure ROS and NO generation ROS and NO generation by OMDVR and interbundle nephrons using fluorescent probes. In aim 2 we will determine which of the enzymes responsible for ROS and NO generation is modulated during AngII induced hypertension. We will measure NADPH oxidase, eNOS, nNOS and ecSOD expression in OMDVR and nephrons by real time PCR, western blot of outer medullary homogenates, in situ hybridization and immunocytochemistry. We will also test the effect of NADPH oxidase, eNOS and nNOS gene deletion in ROS and NO generation. In aim3, we will test the hypothesis that hypertension is accompanied by a decreased in oxidant defense mechanisms. In aim 3, we will test the hypothesis that hypertension is accompanied by a decreased in oxidant defense mechanisms. We will examine the effects of gene deletion of extracellular superoxide dismutase and the dopamine D5 receptor on ROS generation and NO bioavailability. We will also determine the extent to which the D5 receptor acts through hemeoxygenase.
除了在逆流交换中起作用外,直肠降血管(DVR)是一种阻力血管,通过它向肾髓质供应血液。本项目的一般假设是,导致高血压的一个基本机制是活性氧(ROS)的产生增加。本子项目要检验的一般假设是,在高血压期间,髓质中ROS产生的增加导致一氧化氮(NO)生物利用度的降低和DVR血管舒张性的增强。初步数据显示血管紧张素II (angiotensin II, AngII)增强了DVR和肾单位中ROS的形成,而抑制ROS的形成增加了DVR NO的形成,减弱了血管收缩。我们将探讨我们的中心假设我们的中心假设有以下具体目标。在目的1中,我们将检验ROS形成调节从维管束分离的外髓DVR (OMDVR)和从束间区分离的外髓肾单位中NO生成的假设。作为NO生物利用度指标,我们将检测AngII诱导高血压对乙酰胆碱对OMDVR血管舒张的影响。我们还将使用荧光探针直接测量OMDVR和束间肾单位产生的ROS和NO。在目的2中,我们将确定在AngII诱导的高血压期间,哪些负责ROS和NO生成的酶被调节。采用实时荧光定量PCR、外髓匀浆western blot、原位杂交和免疫细胞化学检测OMDVR和肾单位中NADPH氧化酶、eNOS、nNOS和ecSOD的表达。我们还将测试NADPH氧化酶、eNOS和nNOS基因缺失对ROS和NO生成的影响。在目的3中,我们将检验高血压伴随着氧化防御机制下降的假设。在目标3中,我们将检验高血压伴随着氧化防御机制下降的假设。我们将研究细胞外超氧化物歧化酶和多巴胺D5受体基因缺失对ROS生成和NO生物利用度的影响。我们还将确定D5受体通过血红素加氧酶作用的程度。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

THOMAS L PALLONE其他文献

THOMAS L PALLONE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('THOMAS L PALLONE', 18)}}的其他基金

Microvascular Transport in the Renal Medulla
肾髓质中的微血管运输
  • 批准号:
    7987443
  • 财政年份:
    2009
  • 资助金额:
    $ 33.6万
  • 项目类别:
Reactive Oxygen Species American Society of Nephrology Fall 2007
活性氧 美国肾脏病学会 2007 年秋季
  • 批准号:
    7407302
  • 财政年份:
    2007
  • 资助金额:
    $ 33.6万
  • 项目类别:
Ouabain and Descending Vasa Recta Ca2+ Signaling
哇巴因和降支直肠 Ca2 信号传导
  • 批准号:
    6968176
  • 财政年份:
    2004
  • 资助金额:
    $ 33.6万
  • 项目类别:
Calcium Signaling in Vasa Recta Endothelium
直肠血管内皮细胞中的钙信号传导
  • 批准号:
    6806087
  • 财政年份:
    2004
  • 资助金额:
    $ 33.6万
  • 项目类别:
Training Grant in Cardiac and Vascular Cell Biology
心脏和血管细胞生物学培训补助金
  • 批准号:
    7017081
  • 财政年份:
    2003
  • 资助金额:
    $ 33.6万
  • 项目类别:
Training Grant in Cardiac and Vascular Cell Biology
心脏和血管细胞生物学培训补助金
  • 批准号:
    6729069
  • 财政年份:
    2003
  • 资助金额:
    $ 33.6万
  • 项目类别:
Training Grant in Cardiac and Vascular Cell Biology
心脏和血管细胞生物学培训补助金
  • 批准号:
    6871280
  • 财政年份:
    2003
  • 资助金额:
    $ 33.6万
  • 项目类别:
VASOMOTOR CONTROL OF DESCENDING VASA RECTA
降血管直肠的血管舒缩控制
  • 批准号:
    6604310
  • 财政年份:
    1999
  • 资助金额:
    $ 33.6万
  • 项目类别:
Vasomotor Control of Descending Vasa Recta
降直肠血管的血管舒缩控制
  • 批准号:
    8322021
  • 财政年份:
    1999
  • 资助金额:
    $ 33.6万
  • 项目类别:
VASOMOTOR CONTROL OF DESCENDING VASA RECTA
降血管直肠的血管舒缩控制
  • 批准号:
    6390257
  • 财政年份:
    1999
  • 资助金额:
    $ 33.6万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了